These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 17208228

  • 1. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y, Chen LL, Tepavcevic V, Ferdman D, Hodges RR, Dartt DA.
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [Abstract] [Full Text] [Related]

  • 2. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J, Morgan G, Tieu D, Schwalb TA, Luo JY, Wheeler LA, Stern ME.
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [Abstract] [Full Text] [Related]

  • 3. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA, Lee B, Whittum-Hudson J, Prendergast RA.
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [Abstract] [Full Text] [Related]

  • 4. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA, Enger C, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [Abstract] [Full Text] [Related]

  • 5. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
    Saito K, Mori S, Date F, Ono M.
    Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
    [Abstract] [Full Text] [Related]

  • 6. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
    Jabs DA, Lee B, Whittum-Hudson JA, Prendergast RA.
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
    [Abstract] [Full Text] [Related]

  • 7. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
    Hayashi Y, Haneji N, Hamano H, Yanagi K.
    Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
    [Abstract] [Full Text] [Related]

  • 8. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA, Prendergast RA, Rorer EM, Hudson AP, Whittum-Hudson JA.
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200
    [Abstract] [Full Text] [Related]

  • 9. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
    Jabs DA, Gérard HC, Wei Y, Campbell AL, Hudson AP, Akpek EK, Lee B, Prendergast RA, Whittum-Hudson JA.
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
    [Abstract] [Full Text] [Related]

  • 10. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP.
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [Abstract] [Full Text] [Related]

  • 11. Presence of nerves and their receptors in mouse and human conjunctival goblet cells.
    Diebold Y, Ríos JD, Hodges RR, Rawe I, Dartt DA.
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2270-82. PubMed ID: 11527940
    [Abstract] [Full Text] [Related]

  • 12. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
    Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, Reis BL, Whitcup SM, Thompson D, Smith JA.
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2609-14. PubMed ID: 12147592
    [Abstract] [Full Text] [Related]

  • 13. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
    Jabs DA, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
    [Abstract] [Full Text] [Related]

  • 14. Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.
    Skarstein K, Holmdahl R, Johannessen AC, Jonsson R.
    Immunology; 1994 Apr; 81(4):497-501. PubMed ID: 8039804
    [Abstract] [Full Text] [Related]

  • 15. The possible etiopathogenic genes of Sjögren's syndrome.
    Takei M, Shiraiwa H, Azuma T, Hayashi Y, Seki N, Sawada S.
    Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA, Lee B, Burek CL, Saboori AM, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [Abstract] [Full Text] [Related]

  • 17. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
    Zoukhri D, Kublin CL.
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
    [Abstract] [Full Text] [Related]

  • 18. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Akpek EK, Jabs DA, Gérard HC, Prendergast RA, Hudson AP, Lee B, Whittum-Hudson JA.
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
    [Abstract] [Full Text] [Related]

  • 19. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N, Hamano H, Yanagi K, Hayashi Y.
    J Immunol; 1994 Sep 15; 153(6):2769-77. PubMed ID: 8077681
    [Abstract] [Full Text] [Related]

  • 20. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M, Yasui N, Ishimaru N, Arakaki R, Hayashi Y.
    Arthritis Rheum; 2004 Dec 15; 50(12):3974-84. PubMed ID: 15593201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.